Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Receptor tyrosine kinase mutations: molecular indicators for therapeutic response or signposts marking important signaling pathways?

Cancer biology & therapy - 1 Dec 2005

Krystal Geoffrey W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal Stromal Tumors
Share to Lung Neoplasms
Share to Mutation
Share to Receptor Protein-Tyrosine Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Signal Transduction

Source

Identifiers

PMID: 16322688
DOI: 10.4161/cbt.4.12.2360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Receptor tyrosine kinase mutations: molecular indicators for therapeutic response or signposts marking important signaling pathways?PMID 16322688Read ↗

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS.Semantic proximity Read ↗

EGFR pharmacogenomics: the story continues to mutate and evolve.Semantic proximity Read ↗

Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017Semantic proximity Read ↗

Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.Semantic proximity Read ↗

Receptor tyrosine kinases: biological functions and anticancer targeted therapySemantic proximity Read ↗

Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors.Semantic proximity Read ↗

Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locationsSemantic proximity Read ↗

Receptor Tyrosine Kinase-Targeted Cancer TherapySemantic proximity Read ↗

Has discovery-based cancer research been a bust?Semantic proximity Read ↗

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSemantic proximity Read ↗

To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting InhibitorsSemantic proximity Read ↗

Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.